Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individual Dose-escalated Bi-daily sc Ghrelin in Cancer Cachexia: a Phase I/II Study

NCT00933361 is registered in ClinicalTrials.gov with Cantonal Hospital of St. Gallen as lead sponsor.

NCT NCT00933361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00933361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individual Dose-escalated Bi-daily sc Ghrelin in Cancer Cachexia: a Phase I/II Study
Lead sponsor
Cantonal Hospital of St. Gallen
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2009
Completion date
December 31, 2011
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, cachexia